BioNTech SE (BNTX) Gross Profit Growth (1y) (2019 - 2026)
Powered by 
Analysis
BioNTech SE (BNTX) Gross Profit Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 63.51% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 126.09% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 33.01% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 57.16% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 351.57% |
| 10 | BioNTech SE | 25.06 Bn | 11.41 Bn | 10.00 Mn | -95.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -95.21% |
| Mar 31, 2026 | -47.50% |
| Dec 31, 2025 | -33.93% |
| Sep 30, 2025 | 36.88% |
| Jun 30, 2025 | 181.32% |
| Mar 31, 2025 | -25.40% |
| Dec 31, 2024 | -27.68% |
| Sep 30, 2024 | 46.60% |
| Jun 30, 2024 | 1,319.55% |
| Mar 31, 2024 | -88.99% |
| Dec 31, 2023 | -66.52% |
| Sep 30, 2023 | -70.76% |
| Jun 30, 2023 | -99.80% |
| Mar 31, 2023 | -77.77% |
| Dec 31, 2022 | -26.21% |
| Sep 30, 2022 | -61.79% |
| Jun 30, 2022 | -59.41% |
| Mar 31, 2022 | 130.96% |
| Dec 31, 2021 | 1,460.03% |
| Sep 30, 2021 | 9,994.47% |